SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Pierre Hutter

Jurgi Camblong

Lars Steinmetz

SOPHiA GENETICS SA

Gene East is a data specialist staffing business that supplies skilled commercial and technical professionals for data-driven clients across the UK, Europe, and the United States.

Gene East

MedTech Engine provides information and resources related to medical breakthroughs, health research, personal health, and medical technology. They cover topics such as chronic illness management, medical procedures, and healthcare industry solutions.

MedTech Engine

Switzerland Innovation Park Basel Area provides ready-made and customizable workspaces for various teams, focusing on innovation in healthcare, life sciences, and technology.

Metric
Company Name	SOPHiA GENETICS SA	Gene East	MedTech Engine	Switzerland Innovation Park Basel Area
Symbol	SOPH
MSH ID	COM:SOPHIAGENETICS	COM:GENE-EAST	COM:MEDTECHENGINE	COM:SIP-BASELAREA
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Commercial & Professional Services	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical - Healthcare Information Services	Recruitment	Health Information Services	Real Estate
Country	CH	GB	US	CH
Stage
Employee Count	430
Website	sophiagenetics.com	gene-east.com	medtechengine.com	sip-baselarea.com
LinkedIn			medtechengine	switzerland-innovation-park-basel-area
Founders

Metric
Market Cap	299.42M
Enterprise Value
Monthly Web Traffic	40.38K
Web Traffic Growth	0.59
Valuation
Raised Capital	15M

Metric
Revenue	62.37M
Revenue (LTM)
Revenue (NTM)
Gross Profit	36.68M
EBITDA	-68.57M
Operating Income	-76.91M
Net Income	-78.98M
EPS	-1.22
Diluted EPS	-1.22
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.69
Operating Profit Margin	-1.07
EBITDA Margin	-1.10
Net Profit Margin	-1.03
Return on Equity	-0.47
Return on Assets	-0.37
Return on Capital Employed	-0.44

COM:SOPHIAGENETICS

Sophia Genetics

Last Close

3.94

14/02 21:00

Market Cap

299.42M

Beta: -

Volume Today

138.45K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-4.07
P/B Ratio	1.77
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.65
EV Multiple	-4.29

Metric
Days Sales Outstanding	60.81
Days Payables Outstanding	122.00
Days Inventory Outstanding	121.59
Operating Cycle	210.57
Cash Conversion Cycle	109.45
Asset Turnover	0.36

Metric
Operating Cash Flow	-48.58M
Free Cash Flow	-57.80M
Cash Flow to Debt	-2.60
Operating Cash Flow/Sales	-0.72
Free Cash Flow Yield	-0.21

Metric
Cash & Equivalents	123.25M
Accounts Receivable	-6.50M
Inventory	6.48M
Goodwill	9.00M
Debt to Capitalization	0.12
Debt to Assets	0.09
Current Ratio	5.30
Quick Ratio	4.17

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.23
R&D to Revenue	0.58
SG&A to Revenue	0.92